What DNA Can Tell Us About Dog Evolution

Dog diversity unveiled by international DNA database

View  Transcript

The collection of close to 2,000 samples provides an unbiased view of canine genetics. 

Transcript

Host: 

Welcome to Health Lab, your destination for news and stories about the future of healthcare. Today: What DNA Can Tell Us About Dog Evolution. Dog diversity unveiled by international DNA database. The collection of close to 2,000 samples provides an unbiased view of canine genetics.

An international consortium of scientists, led by Jeff Kidd, Ph.D., of the University of Michigan, Jennifer R. S. Meadows of Uppsala University in Sweden, and Elaine A. Ostrander, Ph.D. of the NIH National Human Genome Research Institute, is using an unprecedentedly large database of canine DNA to take an unbiased look at how our furry friends evolved into the various breeds we know and love.

A paper, published in the journal Genome Biology, outlines what the Dog10K project discovered after sequencing the genomes of close to 2,000 samples from 321 different breed dogs, wild dogs, coyotes, and wolves, and comparing them to one reference sample—that of a German Shepherd named Mischka.

Analyzing more than 48 million pieces of genetic information, they discovered that each breed dog had around 3 million single nucleotide polymorphism differences.

These SNPs or “snips” are what account for most of the genetic variation among people and dogs alike.

They also found 26,000 deleted sequences that were present in the German Shepherd but not in the comparison breed and 14,000 that were in the compared breed but missing from Mischka’s DNA.

“We did an analysis to see how similar the dogs were to each other, and it ended up that we could divide them into around 25 major groups that pretty much match up with what people would have expected based on breed origin, the dogs’ type, size and coloration,” said Kidd.

Most of the varying genes, he added, had to do with morphology, confirming that the breed differences were driven by how the dogs look.

Relative to dogs, wolves had around 14% more variation. And wild village dogs—dogs that live amongst people in villages or cities but aren’t kept as pets—exhibited more genetic variation than breed dogs.

The data set, which was processed using the Great Lakes high-performing computing cluster at U of M, also revealed an unusual amount of retrogenes, a new gene that forms when RNA gets turned back into DNA and inserted back into the genome in a different spot.

The study found 926 retrogenes, the most famous of which, says Kidd, is a retrogene called FGF4, which results in the short leg phenotype seen in dachshunds and corgis.

“Dogs tend to have an increased amount of retrogenes which have resulted in mutations that were selected for, that perhaps people found cute and bred more of,” said Kidd.

His lab is attempting to figure out why retrogenes and insertions happen so frequently in dogs.

One of the benefits of the Dog10K consortium is its size, which will enable researchers at U-M and elsewhere to examine the genetic underpinnings of other canine characteristics and even common diseases in dogs, such as cancer.

For more on this story and others like it, visit michiganmedicine.org/health-lab. Health Lab is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can subscribe to Health Lab wherever you listen to podcasts.


More Articles About:

Healthcare NIH Dogs Michigan Medicine podcast
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells

Health Lab Podcast

Listen to more Health Lab podcasts - a part of the Michigan Medicine Podcast Network.

Related

dogs collage
Health Lab

Dog diversity unveiled by international DNA database

A new paper, published in the journal Genome Biology, outlines what the Dog10K project discovered after sequencing the genomes of close to 2,000 samples from 321 different breed dogs, wild dogs, coyotes, and wolves, and comparing them to one reference sample—that of a German Shepherd named Mischka.

Featured News & Stories

UMich Med Mosaic on blue background with colorful geometric shapes
UMich Med Mosaic

Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

Human Rabies Exposures Growing Across the Country

Infectious disease experts weigh in on what to do if you think you’ve been exposed to rabies.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Learning Together: Making Space for Growth at Work

What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Minding memory above a microphone on a blue background
Minding Memory

Can Your Voice Reveal Early Signs of Alzheimer’s?

In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders. Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease. The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.